Cite

HARVARD Citation

    Gelmont, D. et al. (2016). Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long‐term, placebo‐controlled study of Alzheimer's disease. Alzheimer's & dementia. 2 (2), pp. 131-139. [Online]. 
  
Back to record